Exportando "fracasso": Porquê a pesquisa de países desenvolvidos pode não benefi ciar os países em desenvolvimento

J. Jaime Miranda; M. Justin Zaman

doi:10.1590/S0034-89102010000100020

Exportando "fracasso": Porquê a pesquisa de países desenvolvidos pode não benefi ciar os países em desenvolvimento

Translated title of the contribution: Exporting "failure": Why research from rich countries may not benefit the developing world

J. Jaime Miranda
, M. Justin Zaman

School of Medicine

London School of Hygiene and Tropical Medicine
University College London

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Abstract

The '10/90 gap' was fi rst highlighted by the Global Forum for Health Research. It refers to the fi nding that 90% of worldwide medical research expenditure is targeted at problems affecting only 10% of the world's population. Applying research results from the rich world to the problems of the poor may be a tempting, potentially easy and convenient solution for this gap. This paper had the objective of presenting arguments that such an approach runs the risk of exporting failure. Health interventions that are shown to be effective in the specific context of a Western industrialized setting will not necessarily work in the developing world.

Translated title of the contribution	Exporting "failure": Why research from rich countries may not benefit the developing world
Original language	Portuguese (Brazil)
Pages (from-to)	185-189
Number of pages	5
Journal	Revista de Saude Publica
Volume	44
Issue number	1
DOIs	https://doi.org/10.1590/S0034-89102010000100020
State	Published - Feb 2010

Keywords

Descriptors: Biomedical research
Developed countries
Developing countries
Evidence-based medicine
Technical cooperation
Trends

Access to Document

10.1590/S0034-89102010000100020

Cite this

@article{f8877013eeed41929340754122c8b393,

title = "Exportando {"}fracasso{"}: Porqu{\^e} a pesquisa de pa{\'i}ses desenvolvidos pode n{\~a}o benefi ciar os pa{\'i}ses em desenvolvimento",

abstract = "The '10/90 gap' was fi rst highlighted by the Global Forum for Health Research. It refers to the fi nding that 90\% of worldwide medical research expenditure is targeted at problems affecting only 10\% of the world's population. Applying research results from the rich world to the problems of the poor may be a tempting, potentially easy and convenient solution for this gap. This paper had the objective of presenting arguments that such an approach runs the risk of exporting failure. Health interventions that are shown to be effective in the specific context of a Western industrialized setting will not necessarily work in the developing world.",

keywords = "Descriptors: Biomedical research, Developed countries, Developing countries, Evidence-based medicine, Technical cooperation, Trends",

author = "Miranda, \{J. Jaime\} and Zaman, \{M. Justin\}",

year = "2010",

month = feb,

doi = "10.1590/S0034-89102010000100020",

language = "Portugu{\'e}s (Brasil)",

volume = "44",

pages = "185--189",

journal = "Revista de Saude Publica",

issn = "0034-8910",

number = "1",

}

TY - JOUR

T1 - Exportando "fracasso"

T2 - Porquê a pesquisa de países desenvolvidos pode não benefi ciar os países em desenvolvimento

AU - Miranda, J. Jaime

AU - Zaman, M. Justin

PY - 2010/2

Y1 - 2010/2

N2 - The '10/90 gap' was fi rst highlighted by the Global Forum for Health Research. It refers to the fi nding that 90% of worldwide medical research expenditure is targeted at problems affecting only 10% of the world's population. Applying research results from the rich world to the problems of the poor may be a tempting, potentially easy and convenient solution for this gap. This paper had the objective of presenting arguments that such an approach runs the risk of exporting failure. Health interventions that are shown to be effective in the specific context of a Western industrialized setting will not necessarily work in the developing world.

AB - The '10/90 gap' was fi rst highlighted by the Global Forum for Health Research. It refers to the fi nding that 90% of worldwide medical research expenditure is targeted at problems affecting only 10% of the world's population. Applying research results from the rich world to the problems of the poor may be a tempting, potentially easy and convenient solution for this gap. This paper had the objective of presenting arguments that such an approach runs the risk of exporting failure. Health interventions that are shown to be effective in the specific context of a Western industrialized setting will not necessarily work in the developing world.

KW - Descriptors: Biomedical research

KW - Developed countries

KW - Developing countries

KW - Evidence-based medicine

KW - Technical cooperation

KW - Trends

UR - https://www.scopus.com/pages/publications/77953918886

U2 - 10.1590/S0034-89102010000100020

DO - 10.1590/S0034-89102010000100020

M3 - Artículo

AN - SCOPUS:77953918886

SN - 0034-8910

VL - 44

SP - 185

EP - 189

JO - Revista de Saude Publica

JF - Revista de Saude Publica

IS - 1

ER -

Exportando "fracasso": Porquê a pesquisa de países desenvolvidos pode não benefi ciar os países em desenvolvimento

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this